
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Ron Lanton, of True North Political Solutions, interviews Jennifer Mallon, vice president and general counsel of the National Community Pharmacists Association, on the health policy check-up segment.
Ron Lanton, of True North Political Solutions, interviews Jennifer Mallon, vice president and general counsel of the National Community Pharmacists Association, on the health policy check-up segment.






